Amicus Therapeutics (FOLD) Reports Smaller Than Expected Q1 Loss; Revs Light
FOLD Hot Sheet
Revenue Growth %: +30.0%Financial Fact:
Impairment of leasehold improvements: 0
Today's EPS Names:
TARO, BRLI, TLB, More
Amicus Therapeutics, Inc. (Nasdaq: FOLD) reports a Q1 non-GAAP loss of $0.46, 18 cents better than the analyst estimate of ($0.64). Revenue for the quarter was $4.61 million, versus the consensus of $6.34 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Patterson Companies, Inc. (PDCO) Tops Q4 EPS by 5c; Guides FY12
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
